Citadel Advisors »

Entrada Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $987k 70k 14.17
2022-06-30 $158k 13k 12.20
2022-03-31 $605k 64k 9.39
2021-12-31 $1.9M 109k 17.12

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
T. Rowe Price Associates
BlackRock
Redmile Group
Vanguard Group
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
American Century Companies
Northern Trust
FMR

View all funds holding Entrada Therapeutics